Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions.
The post A New Era for Cell and Gene Therapy Signals New Market Opportunities appeared first on MedCity News.
